Healthy Inc > Blog > B2B pharma marketplace
Posted on:

What is the use of artesunate and amodiaquine tablets?

In the pharmaceutical industry, the combination of Artesunate and Amodiaquine (AS+AQ) is a cornerstone of Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this fixed-dose combination (FDC) as a vital public health tool, specifically engineered to combat Plasmodium falciparum malaria by providing a “one-two punch” that eliminates parasites at different stages of their life cycle.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated as a first-line therapy for acute, uncomplicated malaria infections, especially in regions with high chloroquine resistance.

  • Pediatric and Adult Populations: Available in specific weight-based strengths (e.g., 25/67.5 mg, 50/135 mg, and 100/270 mg) to ensure precise dosing and reduce the risk of sub-therapeutic treatment.

  • Rapid Parasite Clearance: Used to achieve high cure rates (typically >95%) and to prevent the progression of the disease into severe, life-threatening malaria.

Mechanism of Action

This FDC utilizes two distinct chemical classes to ensure maximum parasiticidal effect:

Artesunate (Artemisinin Derivative): It acts rapidly by reacting with the iron in the parasite’s heme to generate reactive free radicals. These radicals cause widespread damage to the parasite’s cell membranes and essential proteins, resulting in a rapid “knockdown” of the parasite load.

Amodiaquine (4-Aminoquinoline): It acts as a long-acting blood schizontocide. It interferes with the parasite’s ability to detoxify heme (converting it into non-toxic hemozoin). The resulting accumulation of toxic free heme leads to the death of any parasites that survived the initial Artesunate burst.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+AQ is a technically sensitive product that demands high-tier quality control:

  • Bilayer Tablet Technology: Because Artesunate is highly sensitive to moisture and can interact with the Amodiaquine salt, we often utilize bilayer compression. This physical separation within a single tablet enhances the stability and shelf-life of the product.

  • Hygroscopic Protection: Artesunate is moisture-labile. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to provide a superior moisture barrier, ensuring the tablets remain stable in Zone IVb (hot and humid) climates.

  • Global Health Compliance: This combination is a staple for international health tenders (e.g., Global Fund, USAID). Our Mumbai-based facility is optimized for high-capacity production with full CTD/eCTD Dossier support for rapid international registration.

  • Safety Monitoring: We adhere to strict API standards to minimize the risk of rare adverse effects like neutropenia or hepatotoxicity, ensuring the product is as safe as it is effective.

Artesunate Amodiaquine Tablets

Posted on:

What is the use of artesunate mefloquine?

In the pharmaceutical industry, the combination of Artesunate and Mefloquine (ASMQ) is a high-efficacy Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this fixed-dose combination (FDC) as a critical therapeutic option for regions with multi-drug resistant malaria, as it pairs the fastest-acting antimalarial with one of the longest-lasting ones.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Primarily indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum.

  • Multi-Drug Resistant Regions: It is a first-line therapy in areas where parasites have developed resistance to other ACTs (such as Southeast Asia and parts of South America).

  • Prevention of Transmission: By rapidly clearing the parasite load, it reduces the reservoir of infection within a community, helping to curb the spread of malaria.

Mechanism of Action

This combination offers a “synergistic blockade” against the malaria parasite:

Artesunate (Fast-Acting): Quickly reduces the parasite biomass by generating reactive free radicals that disrupt the parasite’s cell membranes and essential proteins.

Mefloquine (Long-Acting): A quinoline methanol derivative that acts by interfering with the parasite’s ability to detoxify heme (the byproduct of hemoglobin digestion). Its long half-life ensures that any remaining parasites are eliminated over several weeks, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, ASMQ is a technically sophisticated product that demands high quality standards:

  • Stability & Hygroscopicity: Artesunate is highly sensitive to moisture. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and strictly controlled, low-humidity production environments to prevent degradation during export to tropical Zone IVb climates.

  • Side Effect Mitigation: Mefloquine is sometimes associated with neurological side effects. By formulating it as an FDC with Artesunate, we ensure precise dosing which helps maintain the therapeutic window and improves the safety profile compared to loosely combined monotherapies.

  • Fixed-Dose Combination (FDC) Technology: We specialize in the complex formulation required to keep both APIs stable within a single tablet, ensuring consistent dissolution and bioavailability for both components.

  • Global Export Hub: Operating from Mumbai, we provide the CTD/eCTD Dossiers and stability data required for registration in international markets, supporting B2B partners and government tenders in malaria-endemic regions.

Artesunate Mefloquine Tablets

Posted on:

What is the use of artesunate sulfadoxine pyrimethamine tablet?

In the pharmaceutical industry, the combination of Artesunate and Sulfadoxine-Pyrimethamine (AS+SP) is a powerful Artemisinin-based Combination Therapy (ACT). As a pharmacist, I characterize this fixed-dose combination (FDC) as a strategic multi-target treatment designed to clear parasites rapidly while providing a long-acting “chemical umbrella” to prevent the recurrence of infection.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum in areas where the parasite remains sensitive to the SP component.

  • Rapid Parasite Clearance: The Artesunate component ensures that the parasite load in the blood is reduced within hours, preventing the onset of severe malaria.

  • Prevention of Recrudescence: The long-acting Sulfadoxine and Pyrimethamine components remain in the bloodstream for weeks to kill any residual parasites.

  • Intermittent Preventive Treatment (IPT): In specific high-risk regions, this combination is sometimes utilized in pregnancy (IPTp) or for infants (IPTi) to reduce the burden of malaria.

Mechanism of Action

This combination employs a dual-mechanism approach to ensure parasitic death:

Artesunate (Fast-Acting): Generates reactive free radicals that damage the parasite’s proteins and membranes by reacting with the iron in the parasite’s food vacuole. It targets the asexual erythrocytic stages.

Sulfadoxine & Pyrimethamine (Long-Acting): These act as sequential inhibitors of folic acid synthesis. Sulfadoxine inhibits the enzyme dihydropteroate synthase, while Pyrimethamine inhibits dihydrofolate reductase. Since parasites must synthesize their own folates for DNA production, this blockade effectively halts their replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+SP is a specialized product requiring high-tier regulatory compliance:

  • Stability Management: Artesunate is highly sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and low-humidity manufacturing zones to protect the integrity of the Artesunate API during storage and transit.

  • Fixed-Dose Precision: We ensure that the ratio of Sulfadoxine to Pyrimethamine is precisely 20:1 (typically 500 mg/25 mg) to maintain the synergistic effect while minimizing potential side effects.

  • Global Export Niche: This combination is a staple for B2B distributors and government health tenders in sub-Saharan Africa and Southeast Asia. Our Mumbai hub is optimized for high-capacity production to meet international public health demands.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD documentation and stability data for Zone IVb to facilitate smooth registration in malaria-endemic international markets.

Artesunate Sulphadoxine Pyrimethamine Tablets

Posted on:

What is the use of artesunate sulfadoxine pyrimethamine tablet?

In the pharmaceutical industry, the combination of Artesunate and Sulfadoxine-Pyrimethamine (AS+SP) is a powerful Artemisinin-based Combination Therapy (ACT). As a pharmacist, I characterize this fixed-dose combination (FDC) as a strategic multi-target treatment designed to clear parasites rapidly while providing a long-acting “chemical umbrella” to prevent the recurrence of infection.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum in areas where the parasite remains sensitive to the SP component.

  • Rapid Parasite Clearance: The Artesunate component ensures that the parasite load in the blood is reduced within hours, preventing the onset of severe malaria.

  • Prevention of Recrudescence: The long-acting Sulfadoxine and Pyrimethamine components remain in the bloodstream for weeks to kill any residual parasites.

  • Intermittent Preventive Treatment (IPT): In specific high-risk regions, this combination is sometimes utilized in pregnancy (IPTp) or for infants (IPTi) to reduce the burden of malaria.

  • Mechanism of Action

This combination employs a dual-mechanism approach to ensure parasitic death:

Artesunate (Fast-Acting): Generates reactive free radicals that damage the parasite’s proteins and membranes by reacting with the iron in the parasite’s food vacuole. It targets the asexual erythrocytic stages.

Sulfadoxine & Pyrimethamine (Long-Acting): These act as sequential inhibitors of folic acid synthesis. Sulfadoxine inhibits the enzyme dihydropteroate synthase, while Pyrimethamine inhibits dihydrofolate reductase. Since parasites must synthesize their own folates for DNA production, this blockade effectively halts their replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+SP is a specialized product requiring high-tier regulatory compliance:

  • Stability Management: Artesunate is highly sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and low-humidity manufacturing zones to protect the integrity of the Artesunate API during storage and transit.

  • Fixed-Dose Precision: We ensure that the ratio of Sulfadoxine to Pyrimethamine is precisely 20:1 (typically 500mg/25mg) to maintain the synergistic effect while minimizing potential side effects.

  • Global Export Niche: This combination is a staple for B2B distributors and government health tenders in sub-Saharan Africa and Southeast Asia. Our Mumbai hub is optimized for high-capacity production to meet international public health demands.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD documentation and stability data for Zone IVb to facilitate smooth registration in malaria-endemic international markets.

 

Posted on:

What is the use of artesunate tablet?

In the pharmaceutical industry, Artesunate tablets (commonly 50 mg, 100 mg, or 200 mg) are a semi-synthetic derivative of artemisinin. As a pharmacist, I view Artesunate as one of the most powerful and fast-acting antimalarial agents available, serving as the cornerstone of modern malaria therapy to prevent the progression of the disease to severe or fatal stages.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum.

  • ACT Combination Therapy: Following WHO guidelines, Artesunate is almost always used in Artemisinin-based Combination Therapy (ACT). It is paired with longer-acting partner drugs (like Amodiaquine, Mefloquine, or Sulfadoxine-Pyrimethamine) to ensure a complete cure and prevent resistance.

  • Step-down Therapy: Used as an oral follow-up treatment after an initial course of parenteral (injectable) artesunate for severe malaria, once the patient can tolerate oral medication.

  • Chloroquine-Resistant Malaria: Effective in regions where the parasite has developed high levels of resistance to traditional antimalarials.

Mechanism of Action

Artesunate is a “prodrug” that is rapidly converted into its active metabolite, dihydroartemisinin (DHA). It acts by reacting with the iron in the parasite’s heme (from digested hemoglobin) to create reactive free radicals. These radicals cause extensive damage to the parasite’s proteins and membranes, specifically targeting the asexual erythrocytic stages, leading to a rapid reduction in parasite biomass.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artesunate is a high-priority, technically sensitive molecule:

  • Hydrolytic Stability: Artesunate is highly sensitive to moisture and can easily degrade into DHA in the presence of humidity. As a WHO-GMP manufacturer, we utilize strictly controlled, low-humidity environments and Alu-Alu blister packaging to ensure product stability for 24 months.

  • Fixed-Dose Combination (FDC) Expertise: We specialize in the complex formulation of Artesunate with partner drugs, ensuring that each API remains stable and bioavailable within a single tablet matrix.

  • Global Health Tenders: Artesunate is a staple for international NGOs, UNICEF, and the Global Fund. Our Mumbai facility is optimized for the high-volume production and the rigorous CTD/eCTD documentation required for these global contracts.

  • Quality Assurance: Each batch is tested against BP/USP/IP standards to ensure precise potency, which is critical in preventing the emergence of drug-resistant malaria strains.

Artesunate Tablets

Posted on:

What is ascorbic acid vitamin C tablets used for?

In the pharmaceutical industry, Ascorbic Acid (Vitamin C) tablets (commonly available in 100 mg, 500 mg, and 1000 mg) are the most widely recognized essential water-soluble vitamins. As a pharmacist, I view Vitamin C not just as a supplement, but as a vital cofactor for collagen synthesis and a primary biological antioxidant that protects cellular components from oxidative stress.

Primary Clinical Uses

  • Treatment of Scurvy: The definitive treatment for Vitamin C deficiency, characterized by capillary fragility, bleeding gums, and impaired wound healing.

  • Immune System Enhancement: Used to support both innate and adaptive immune functions. It stimulates the production and function of white blood cells (leukocytes) and acts as a barrier against pathogens.

  • Iron Absorption: Frequently co-prescribed with iron supplements to treat anemia, as Vitamin C significantly enhances the absorption of non-heme iron in the gastrointestinal tract.

  • Supportive Therapy: Used to promote wound healing post-surgery, treat pressure sores, and manage chronic infections where oxidative stress is high.

Mechanism of Action

Ascorbic Acid acts as an electron donor for eight different enzymes. Its most critical role is in collagen hydroxylation, where it stabilizes the triple helix of collagen fibers, providing structural integrity to skin, blood vessels, and bones. As a potent antioxidant, it neutralizes reactive oxygen species (ROS), thereby preventing damage to DNA, proteins, and lipids.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Vitamin C is a high-volume product that requires specialized environmental controls:

  • Oxidation Control: Ascorbic Acid is highly sensitive to light, heat, and moisture, which causes it to turn yellow or brown. As a WHO-GMP manufacturer, we utilize strictly controlled RH (Relative Humidity) environments and opaque packaging to prevent degradation.

  • Chewable & Effervescent Varieties: To improve patient compliance, we focus on chewable tablets with advanced taste-masking for its natural acidity, as well as effervescent tablets for rapid absorption and better “mouthfeel.”

  • Global Export Staple: Vitamin C is a consistent top-seller in B2B marketplaces and international tenders. Our Mumbai-based facility provides customized strengths and packaging (strip/blister/bulk bottles) for the African, CIS, and Southeast Asian markets.

  • Quality Standards: We ensure all batches comply with BP/USP/IP monographs, specifically testing for “Related Substances” and “Assay” to guarantee the 24-month shelf life required for international shipping.

Ascorbic Acid Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (available in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (available in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of amodiaquine hydrochloride?

In the pharmaceutical industry, Amodiaquine Hydrochloride is a 4-aminoquinoline derivative that serves as a potent antimalarial agent. As a pharmacist, I characterize Amodiaquine as a critical fast-acting blood schizontocide, particularly indispensable in regions where there is established resistance to older molecules like Chloroquine.

Primary Clinical Uses

  • Treatment of Plasmodium falciparum: It is highly effective against the asexual erythrocytic stages of P. falciparum.

  • ACT Combination Therapy: In modern medicine, Amodiaquine is rarely used as a monotherapy. It is most commonly used in Artemisinin-based Combination Therapy (ACT), specifically as Artesunate + Amodiaquine (AS+AQ), which is a WHO-recommended first-line treatment for uncomplicated malaria.

  • Seasonal Malaria Chemoprevention (SMC): Used in combination with Sulfadoxine-Pyrimethamine (SP) for the intermittent administration of full treatment courses during the malaria season to prevent illness in children.

    Mechanism of Action

Amodiaquine acts primarily by inhibiting the polymerization of hemozoin. When the malaria parasite digests the host’s hemoglobin, it releases toxic free heme. Amodiaquine enters the parasite’s food vacuole and prevents the detoxification of this heme into non-toxic hemozoin crystals. The resulting accumulation of free heme is toxic to the parasite, leading to its rapid destruction.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Amodiaquine is a high-priority molecule for public health tenders and international B2B supply:

  • Fixed-Dose Combination (FDC): The primary manufacturing challenge is creating stable FDCs with Artesunate. Since Artesunate is sensitive to moisture, we utilize specialized bilayer tablet technology or advanced granulation techniques to ensure both APIs remain stable.

  • Standardization: We ensure the API meets BP/USP/IP specifications, with a focus on controlling the impurity profile to minimize the risk of rare but serious side effects like agranulocytosis or hepatotoxicity.

  • Global Export Niche: Amodiaquine is a staple for the African and Southeast Asian markets. As a WHO-GMP manufacturer, our facility in Mumbai is optimized for high-volume production for NGO and government tenders (e.g., Global Fund, USAID).

  • Regulatory Readiness: We provide the CTD/eCTD Dossiers and stability data required for registration in malaria-endemic zones, ensuring the product maintains its potency in Zone IVb (hot and humid) conditions.

Amodiaquine Tablets

 

Posted on:

What is the use of Artemether and Lumefantrine dispersible tablet?

In the pharmaceutical industry, Artemether and Lumefantrine dispersible tablets (standardized at 20 mg / 120 mg) are the specialized pediatric formulation of the gold-standard Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view the “dispersible” delivery system as a life-saving innovation designed to ensure accurate dosing and rapid absorption in infants and children, who are the most vulnerable to malaria.

Primary Clinical Uses

  • Pediatric Uncomplicated Malaria: Specifically indicated for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum in infants and children weighing between 5 kg and 35 kg.

  • Chloroquine-Resistant Strains: First-line defense in regions where malaria parasites have developed resistance to older monotherapies.

  • Rapid Parasite Clearance: Used to quickly reduce the parasite biomass in the blood to prevent the progression of uncomplicated malaria into life-threatening severe or cerebral malaria.

Mechanism of Action

This combination employs a “dual-speed” parasiticidal effect:

Artemether: A fast-acting component that generates reactive free radicals. These radicals damage the parasite’s proteins and membranes, providing an immediate “knockdown” of the infection.

Lumefantrine: A long-acting component that clears any remaining parasites over several days. Its presence in the blood prevents the infection from returning (recrudescence) after the short-lived Artemether has cleared.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, the dispersible tablet is a technically demanding product that serves a massive public health niche:

  • Dispersibility Standards: As a WHO-GMP quality parameter, these tablets must disintegrate in a small amount of water or milk within 1 to 2 minutes to form a smooth suspension, ensuring the child receives the full dose without the risk of choking.

  • Taste-Masking Technology: Artemether and Lumefantrine are naturally very bitter. For a manufacturing firm, the use of advanced sweetening and flavoring agents (such as cherry or strawberry) is essential to prevent the child from spitting out the medicine.

  • Stabilization for Tropical Climates: Both APIs, particularly Artemether, are sensitive to heat and moisture. We utilize Alu-Alu blister packaging to ensure a 24-month shelf life in Zone IVb environments (hot and humid), common in Africa and Southeast Asia.

  • Global Health Tenders: These are high-volume essential medicines for international NGOs, UNICEF, and the Global Fund. Our Mumbai facility is optimized for the high-capacity production and the rigorous CTD/eCTD documentation required for these global contracts.

Artemether & Lumefantrine Tablets

Add to cart